Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
OCLG On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).

oncologix tech inc (OCLG) Snapshot

Open
$0.01
Previous Close
$0.01
Day High
$0.01
Day Low
$0.0070
52 Week High
12/10/12 - $0.27
52 Week Low
03/19/13 - $0.0051
Market Cap
899.2K
Average Volume 10 Days
77.2K
EPS TTM
--
Shares Outstanding
61.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ONCOLOGIX TECH INC (OCLG)

Related News

No related news articles were found.

oncologix tech inc (OCLG) Related Businessweek News

No Related Businessweek News Found

oncologix tech inc (OCLG) Details

Oncologix Tech, Inc., a development stage company, focuses on the development of medical device. It is developing a microsphere for use as a means of micro-arterial brachytherapy in the treatment of soft tissue cancer tumors in the liver. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is headquartered in Grand Rapids, Michigan.

2 Employees
Last Reported Date: 12/7/12
Founded in 1995

oncologix tech inc (OCLG) Top Compensated Officers

Chief Financial Officer and Controller
Total Annual Compensation: $72.9K
Compensation as of Fiscal Year 2012.

oncologix tech inc (OCLG) Key Developments

Oncologix Tech, Inc. Elects Wayne Erwin as Chairman and CEO

Oncologix Tech Inc. has purchased all of the outstanding common stock of Dotolo Research Corporation. Wayne Erwin, CEO of Dotolo, who now has been elected Chairman and CEO of Oncologix.

Oncologix Tech, Inc. Announces Management Changes

On March 21, 2013, Anthony Silverman submitted his resignation as Chief Executive Officer, President and Chairman of the Board of Oncologix Tech, Inc., effective March 21, 2013 to pursue retirement. On March 21, 2013, the Board of Directors of the company appointed Barry Griffith as Chief Executive Officer, President and Chairman of the Board. Mr. Griffith has served as a Director of the company since November 2004.

Oncologix Tech, Inc. announced delayed annual 10-K filing

On 11/29/2012, Oncologix Tech, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLG:US $0.01 USD 0.00

OCLG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
pSivida Corp $3.94 USD +0.10
Sirtex Medical Ltd A$12.69 AUD 0.00
View Industry Companies
 

Industry Analysis

OCLG

Industry Average

Valuation OCLG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLOGIX TECH INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.